Expert Perspectives on the Utility of Real-World Data in the Management of Plaque Psoriasis : Episode 9

Video

January 17, 2023

Long-Term Persistence of Biologic Treatment Options for Plaque Psoriasis

Author(s):

Brad Glick, DO, MPH,George Han, MD, PhD

George Han, MD, PhD, provides an overview of the long-term persistence of different biologic treatment options for plaque psoriasis.

EP: 1.Plaque Psoriasis: Current Expansion of the Therapeutic Landscape

EP: 2.Shifting Treatment Approaches to Plaque Psoriasis

EP: 3.Current Role of Topical Therapy for Plaque Psoriasis Treatment

EP: 4.Spectrum of Disease and Current Treatment Options for Plaque Psoriasis

EP: 5.Plaque Psoriasis: Escalating Treatment

EP: 6.Communication With Patients About Plaque Psoriasis Treatment

EP: 7.IL-23 inhibitors for Plaque Psoriasis Treatment

EP: 8.Impact of Treatment Mode of Delivery on Patient Adherence and Plaque Psoriasis Treatment Selection

EP: 9.Long-Term Persistence of Biologic Treatment Options for Plaque Psoriasis

EP: 10.IL-23 Inhibitors and the Current Treatment Landscape for Plaque Psoriasis

EP: 11.Long Term Efficacy And Safety Data: IL-23 Inhibitors in Patients with Moderate to Severe Plaque Psoriasis

EP: 12.BMI and Background Comorbidities that Impact Plaque Psoriasis Treatment

EP: 13.Plaque Psoriasis: Older Populations and Skin of Color

EP: 14.Looking Ahead at Clinical Trial Metrics for Plaque Psoriasis

EP: 15.Plaque Psoriasis: Future Therapeutic Pipeline

Related Videos

Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD

New Findings on Psoriasis Outcomes for Roflumilast Foam 0.3%, with Melinda Gooderham, MD

Methods to Manage Psoriasis Using Oral Therapies, with Andrea Murina, MD

James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists

Melodie Young, ASN, RN: Updates on Therapies for Pediatric Patients with Psoriasis, PsA

Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis

Melinda Gooderham, MD: What Do the New Roflumilast Foam Data Mean for Psoriasis Patients?

Linda Stein Gold, MD, and Bruce Strober, MD, PhD

Linda Stein Gold, MD, and Bruce Strober, MD, PhD

Linda Stein Gold, MD, and Bruce Strober, MD, PhD

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.